Supplemental material
Cell Cycle
Volume 12, 2013 - Issue 13
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
The prognostic and functional role of microRNAs in acute myeloid leukemia
Source:
American Society of Hematology
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Source:
Elsevier BV
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
Source:
American Society of Hematology
High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors.
Source:
American Association for Cancer Research (AACR)
Bortezomib induces heme oxygenase-1 expression in multiple myeloma.
Source:
Informa UK Limited
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
MicroRNA-125b is a novel negative regulator of p53
Source:
Cold Spring Harbor Laboratory
Regulatory mechanisms of B cell responses and the implication in B cell-related diseases
Source:
Springer Science and Business Media LLC
Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.
Source:
Taylor & Francis
miR-125a suppresses malignancy of multiple myeloma by reducing the deubiquitinase USP5.
Source:
Wiley
Camptothecin Induces Apoptosis in Cancer Cells via MicroRNA-125b-Mediated Mitochondrial Pathways
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
MiR-34a Attenuates Paclitaxel-Resistance
Source:
Wiley
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.
Source:
Springer Science and Business Media LLC
LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.
Source:
Wiley
MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis
Source:
Springer Nature
Dysregulation of miR-125b Predicts Poor Response to Therapy in Pediatric Acute Lymphoblastic Leukemia
Source:
Elsevier BV
Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A
Source:
Proceedings of the National Academy of Sciences
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
Source:
Proceedings of the National Academy of Sciences
Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells
Source:
Springer Nature
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.
Source:
American Association for Cancer Research (AACR)
Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish.
Source:
American Society of Hematology
Guideline
Source:
Wiley
MicroRNA: important player in the pathobiology of multiple myeloma.
Source:
Hindawi Limited
Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.
Source:
Springer Science and Business Media LLC
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
Source:
Impact Journals, LLC
miR-34a repression of SIRT1 regulates apoptosis
Source:
Proceedings of the National Academy of Sciences
Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.
Source:
Springer Science and Business Media LLC
MicroRNA expression profiles classify human cancers
Source:
Springer Science and Business Media LLC
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB.
Source:
Elsevier BV
miR-125a-5p INHIBITION ACTIVATES p53 IN MM CELLS
Source:
Wiley
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma.
Source:
Frontiers Media SA
NF-kappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction.
Source:
American Association for Cancer Research (AACR)
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Source:
Public Library of Science (PLoS)
MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
Source:
Public Library of Science
The effects of microRNAs on glucocorticoid responsiveness.
Source:
Springer Science and Business Media LLC
Linking provided by
